Company Filing History:
Years Active: 2024
Title: Cédric Blanpain: Innovator in Cancer Research
Introduction
Cédric Blanpain is a prominent inventor based in Ohain, Belgium. He has made significant contributions to the field of cancer research, particularly in the detection and quantification of circulating tumor cells. His innovative work has the potential to enhance cancer diagnostics and treatment strategies.
Latest Patents
Cédric Blanpain holds a patent for the invention titled "Detection, quantification and/or isolation of circulating tumor cells based on the expression of CD321 marker." This patent discloses CD321 as a useful global marker of circulating tumor cells (CTCs) and provides related methods and kits relying on the detection of CD321. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Cédric Blanpain is affiliated with the Université Libre de Bruxelles, where he conducts research and develops innovative solutions in the field of oncology. His work is characterized by a strong focus on improving cancer detection methods, which can lead to better patient outcomes.
Collaborations
Cédric has collaborated with notable colleagues, including Panagiota Sotiropoulou and Ievgenia Pastushenko. These collaborations have further enriched his research and contributed to the advancement of cancer diagnostics.
Conclusion
Cédric Blanpain is a dedicated inventor whose work in cancer research is paving the way for improved diagnostic techniques. His contributions are vital in the ongoing fight against cancer, and his innovative spirit continues to inspire advancements in medical science.